Articles with "ido1" as a keyword



Ginsenoside Rb3 Promotes Opa1‐Mediated Regenerative Neurogenesis via Activating the Ido1 Pathway in Ischemic Stroke

Sign Up to like & get
recommendations!
Published in 2024 at "Phytotherapy Research"

DOI: 10.1002/ptr.8392

Abstract: The activation of neural stem cells (NSCs) residing in the subventricular zone (SVZ) and dentate gyrus (DG) has been shown to promote the restoration of damaged brain tissues. Ginsenoside Rb3 (Rb3) is a bioactive substance… read more here.

Keywords: ido1; rb3; ginsenoside rb3; opa1 mediated ... See more keywords

Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer Immunology, Immunotherapy"

DOI: 10.1007/s00262-019-02306-y

Abstract: The prognostic value of the local immune phenotype in patients with colorectal cancer has been extensively studied. Neoadjuvant radiotherapy and/or chemotherapy may potentially influence these immune responses. In this study, we examined the prognostic role… read more here.

Keywords: ido1; cd8; prognostic value; neoadjuvant chemoradiation ... See more keywords

Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism

Sign Up to like & get
recommendations!
Published in 2021 at "Cardiovascular Toxicology"

DOI: 10.1007/s12012-021-09657-y

Abstract: Indoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme for tryptophan metabolism, involved in immune cell differentiation/maturation and cancer biology. IDO1 is also expressed in cardiomyocytes, but its roles in the cardiovascular system are not fully understood.… read more here.

Keywords: ido1; cardiac hypertrophy; pi3k akt; hypertrophy ... See more keywords

Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.

Sign Up to like & get
recommendations!
Published in 2017 at "European journal of medicinal chemistry"

DOI: 10.1016/j.ejmech.2016.12.029

Abstract: High expression of the immunosuppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1) for a broad range of malignancies is associated with poor patient prognosis, and the enzyme is a validated target for cancer intervention. To identify novel… read more here.

Keywords: ido1; enzyme indoleamine; dioxygenase ido1; ido1 inhibitors ... See more keywords

Indoleamine 2,3‐dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor

Sign Up to like & get
recommendations!
Published in 2017 at "Toxicology and Applied Pharmacology"

DOI: 10.1016/j.taap.2017.03.012

Abstract: ABSTRACT Indoleamine 2,3‐dioxygenase 1 (IDO1) plays a key role in the immune system by regulating tryptophan levels and T cell differentiation. Several tumor types overexpress IDO1 to avoid immune surveillance making IDO1 of interest as… read more here.

Keywords: ido1; aryl hydrocarbon; indoleamine dioxygenase; ido1 inhibitors ... See more keywords

Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.1c01305

Abstract: Indoleamine 2,3-dioxygenase-1 (IDO1) plays an important role in tumor immune escape. However, unsatisfactory clinical efficacies of selective IDO1 inhibitors have impeded their further development, suggesting that they do not exert sufficient antitumor effects by selectively… read more here.

Keywords: cancer; ido2; ido1 ido2; strategy ... See more keywords

Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1).

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.1c01665

Abstract: Since the discovery of the implication of indoleamine 2,3-dioxygenase 1 (IDO1) in tumoral immune resistance in 2003, the search for inhibitors has been intensely pursued both in academia and in pharmaceutical companies, supported by the… read more here.

Keywords: indoleamine dioxygenase; dioxygenase ido1; ido1; ido1 structure ... See more keywords

Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening

Sign Up to like & get
recommendations!
Published in 2019 at "Acta Pharmacologica Sinica"

DOI: 10.1038/s41401-019-0246-4

Abstract: Indoleamine 2,3-dioxygenase 1 (IDO1) is emerging as a promising therapeutic target for the treatment of malignant tumors characterized by dysregulated tryptophan metabolism. However, the antitumor efficacy of existing small-molecule IDO1 inhibitors is still unsatisfactory, and… read more here.

Keywords: ido1; natural products; indoleamine dioxygenase; activity ... See more keywords

IDO1 inhibits ferroptosis by regulating FTO-mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression

Sign Up to like & get
recommendations!
Published in 2025 at "Cell Death Discovery"

DOI: 10.1038/s41420-025-02293-3

Abstract: Indoleamine 2, 3-dioxygenase 1 (IDO1) has been recognized as an enzyme involved in tryptophan catabolism with immunosuppressive ability. This study determined to investigate the impact of IDO1 on glioblastoma multiforme (GBM) cells. Here, we showed… read more here.

Keywords: ido1; slc7a11 mrna; progression; mrna stability ... See more keywords

Synthesis and evaluation of oxindoles as promising inhibitors of the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1.

Sign Up to like & get
recommendations!
Published in 2017 at "MedChemComm"

DOI: 10.1039/c7md00226b

Abstract: Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as an important therapeutic target for the treatment of cancer, chronic infections and other diseases that are associated with immune suppression. Recent developments in understanding the catalytic mechanism of… read more here.

Keywords: ido1; ido1 enzyme; potent compounds; indoleamine dioxygenase ... See more keywords

Discovery of novel IDO1/TDO2 dual inhibitors: a consensus Virtual screening approach with molecular dynamics simulations, and binding free energy analysis

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Biomolecular Structure and Dynamics"

DOI: 10.1080/07391102.2024.2329302

Abstract: Abstract The pursuit of effective cancer immunotherapy drugs remains challenging, with overexpression of indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase 2 (TDO2) allowing cancer cells to evade immune attacks. While several IDO1 inhibitors have undergone… read more here.

Keywords: ido1; dual inhibitors; binding free; tdo2 dual ... See more keywords